Thursday, September 21, 2023
Home 2023 May

Monthly Archives: May 2023

2022 Watch List

Asia-Pacific: A Region of Stability Amidst Economic Uncertainty

Editor / Curator -
2020 Watch List

Hepion (HEPA) Back in the Spotlight, Gains 230% in May.

Editor / Curator -
2023 Watch List

Psycheceutical Bioscience, Inc. Announces Observational Research Results for NeuroDirect™ Ketamine Topical...

Editor / Curator -
2023 Watch List

Video: New Topical Drug Delivery System, NeuroDirect™

Editor / Curator -
2023 Watch List

Topical PTSD Drug Poised for Human Trials.

Editor / Curator -
Uncategorized

Ketamine and Yale University

Editor / Curator -
Zappy Zapolin, Lamar Odom, Roland Rick Perry
2023 Watch List

Adding Psycheceutical Bioscience (BWVI) $0.14 to Watch List. Ketamine.

Editor / Curator -
AI Artificial Intelligence

Khan Academy’s AI Pilot Program.

Editor / Curator -
Biotech News

Pivotal Clinical Trials: Frequently Asked Questions (Sofpromed).

Editor / Curator -

Latest article

20 Minutes with Sekur (SWISF) CEO and Internet Security Expert Alain Ghiai.

Internet News Editor / Curator -
Alain Ghiai, founded the Company and has served as Director and CEO since March 2017. He has served as President and Corporate...

Hapbee’s (HAPB) Revolutionary Sleep Aid Lands on the Shelves of Target.

Client Editor / Curator -
When we first came across Hapbee (HAPB) we described it as having a medical technology (a device) that had the "highest potential...

Adding Cybin (CYBN) to 2024 Top Psychedelic Stocks Watch List.

Psychedelic Stock Review Editor / Curator -
Steve Cohen from Point 72, Acquires 18,950,000 Shares of Cybin.
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.